Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease

OBJECTIVES: Growing evidence argues for a relationship between liver and bone metabolisms. Sclerostin is a secreted glycoprotein and could antagonize osteoblast-mediated bone formation. Previous studies indicated that circulating sclerostin levels may be associated with metabolic parameters with inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fangli, Wang, Yan, Li, Yujue, Tang, Mengjia, Wan, Shan, Tian, Haoming, Chen, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374147/
https://www.ncbi.nlm.nih.gov/pubmed/34421825
http://dx.doi.org/10.3389/fendo.2021.707505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374147/
https://www.ncbi.nlm.nih.gov/pubmed/34421825
http://dx.doi.org/10.3389/fendo.2021.707505

Ejemplares similares